ARTICLE | Clinical News
Cellex regulatory update
July 17, 1995 7:00 AM UTC
The Minneapolis company received U.S. Patent No. 5,416,022 covering an adaptation to its hollow fiber bioreactor technology, making it more suitable for use in research laboratories. The hollow fiber ...